Efficacy and safety of full oral vinorelbine (NVBO) on D1 and
D8 with carboplatin (CBDCA) as first line treatment in advenced
non-small lung cancer (NSCLC) patients: Results of prospective
study in nonrandomized population of 259 patients

a 2013

Efficacy and safety of full oral vinorelbine (NVBO) on D1 and D8 with carboplatin (CBDCA) as first line treatment in advenced non-small lung cancer (NSCLC) patients: Results of prospective study in nonrandomized population of 259 patients

SKŘIČKOVÁ, Jana; Bohdan KADLEC; Ondřej VENCLÍČEK; Tereza JANÁSKOVÁ; Vítězslav KOLEK et. al.

Základní údaje

Originální název

Efficacy and safety of full oral vinorelbine (NVBO) on D1 and D8 with carboplatin (CBDCA) as first line treatment in advenced non-small lung cancer (NSCLC) patients: Results of prospective study in nonrandomized population of 259 patients

Autoři

SKŘIČKOVÁ, Jana (203 Česká republika, garant, domácí); Bohdan KADLEC (203 Česká republika, domácí); Ondřej VENCLÍČEK (203 Česká republika); Tereza JANÁSKOVÁ (203 Česká republika); Vítězslav KOLEK (203 Česká republika); Ivona GRYGÁRKOVÁ (203 Česká republika); Helena ČOUPKOVÁ (203 Česká republika) a Pavel REITERER (203 Česká republika)

Vydání

23rd Annual Congress, European Respiratory Society, 7-11 September 2013, Barcelona, 2013

Další údaje

Jazyk

angličtina

Typ výsledku

Konferenční abstrakt

Obor

30203 Respiratory systems

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 7.125

Kód RIV

RIV/00216224:14110/13:00069321

Organizační jednotka

Lékařská fakulta

ISSN

Klíčová slova anglicky

first-line treatment; NSCLC patients

Změněno: 5. 2. 2014 13:02, Ing. Mgr. Věra Pospíšilíková

Anotace

V originále

Background: The purpose was to evaluate the activity and feasibility of CBDCA together with NVBO in 1st line treatment NSCLC patients. Conclusions: The treatment with NVBO and CBDCA was well tolerated with evidence of high antitumour activity. This combination was active in all groups patients according histology.

Citovat

SKŘIČKOVÁ, Jana; Bohdan KADLEC; Ondřej VENCLÍČEK; Tereza JANÁSKOVÁ; Vítězslav KOLEK; Ivona GRYGÁRKOVÁ; Helena ČOUPKOVÁ a Pavel REITERER. Efficacy and safety of full oral vinorelbine (NVBO) on D1 and D8 with carboplatin (CBDCA) as first line treatment in advenced non-small lung cancer (NSCLC) patients: Results of prospective study in nonrandomized population of 259 patients. In 23rd Annual Congress, European Respiratory Society, 7-11 September 2013, Barcelona. 2013. ISSN 0903-1936.

@proceedings{1122639,
   author = {Skřičková, Jana and Kadlec, Bohdan and Venclíček, Ondřej and Janásková, Tereza and Kolek, Vítězslav and Grygárková, Ivona and Čoupková, Helena and Reiterer, Pavel},
   booktitle = {23rd Annual Congress, European Respiratory Society, 7-11 September 2013, Barcelona},
   keywords = {first-line treatment; NSCLC patients},
   language = {eng},
   title = {Efficacy and safety of full oral vinorelbine (NVBO) on D1 and D8 with carboplatin (CBDCA) as first line treatment in advenced non-small lung cancer (NSCLC) patients: Results of prospective study in nonrandomized population of 259 patients},
   year = {2013}
}

TY  - CONF
ID  - 1122639
AU  - Skřičková, Jana - Kadlec, Bohdan - Venclíček, Ondřej - Janásková, Tereza - Kolek, Vítězslav - Grygárková, Ivona - Čoupková, Helena - Reiterer, Pavel
PY  - 2013
TI  - Efficacy and safety of full oral vinorelbine (NVBO) on D1 and D8 with carboplatin (CBDCA) as first line treatment in advenced non-small lung cancer (NSCLC) patients: Results of prospective study in nonrandomized population of 259 patients
KW  - first-line treatment
KW  - NSCLC patients
N2  - Background: The purpose was to evaluate the activity and feasibility of CBDCA together with NVBO in 1st line treatment NSCLC patients. Conclusions: The treatment with NVBO and CBDCA was well tolerated with evidence of high antitumour activity. This combination was active in all groups patients according histology.
ER  -

SKŘIČKOVÁ, Jana; Bohdan KADLEC; Ondřej VENCLÍČEK; Tereza JANÁSKOVÁ; Vítězslav KOLEK; Ivona GRYGÁRKOVÁ; Helena ČOUPKOVÁ a Pavel REITERER. Efficacy and safety of full oral vinorelbine (NVBO) on D1 and D8 with carboplatin (CBDCA) as first line treatment in advenced non-small lung cancer (NSCLC) patients: Results of prospective study in nonrandomized population of 259 patients. In \textit{23rd Annual Congress, European Respiratory Society, 7-11 September 2013, Barcelona}. 2013. ISSN~0903-1936.

Přehled o publikaci